Alejandra Venegas-Ramirez

Calzada De Tlalpan 4502, C.P. 14080
Tlalpan, DIF 14080, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.

EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.

Journal: Epigenomics

Published: July 23, 2025

Biomass Smoke Exposure Reduces DNA Methylation Levels in PRSS23 (cg23771366) in Women with Chronic Obstructive Pulmonary Disease.

Biomass Smoke Exposure Reduces DNA Methylation Levels in PRSS23 (cg23771366) in Women with Chronic Obstructive Pulmonary Disease.

Journal: Toxics

Published: March 04, 2025

Eosinophilic cytokines and small airway dysfunction in women with COPD: correlation with exposure to biomass smoke versus tobacco smoking.

Eosinophilic cytokines and small airway dysfunction in women with COPD: correlation with exposure to biomass smoke versus tobacco smoking.

Journal: IJTLD open

Published: February 10, 2025

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.

Journal: Respiratory medicine

Published: January 22, 2025

Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.

Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.

Journal: Respiratory research

Published: September 17, 2024

Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease.

Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease.

Journal: Medical sciences (Basel, Switzerland)

Published: August 21, 2024

Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014).

Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014).

Journal: IJID regions

Published: May 09, 2024

Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude.

Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude.

Journal: ERJ open research

Published: April 05, 2024

Altered levels of IFN-γ, IL-4, and IL-5 depend on the TLR4 rs4986790 genotype in COPD smokers but not those exposed to biomass-burning smoke.

Altered levels of IFN-γ, IL-4, and IL-5 depend on the TLR4 rs4986790 genotype in COPD smokers but not those exposed to biomass-burning smoke.

Journal: Frontiers in immunology

Published: April 02, 2024

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass.

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass.

Journal: ERJ open research

Published: February 16, 2024

Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT Study.

Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT Study.

Journal: Pulmonary therapy

Published: January 11, 2024

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.

Journal: Heliyon

Published: November 06, 2023

Showing 1-12 of 93

Last Updated: 09/26/2026